These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25648034)

  • 1. Coronary slow flow phenomenon associated with high serum levels of soluble CD40 ligand and urotensin II: a multi-marker approach.
    Demir B; Caglar IM; Tureli HO; Pirhan O; Aciksari G; Serkan Çifçi ; Cem Özde ; Gedikbasi A; Zorkun C; Demir E; Karakaya O
    Clin Lab; 2014; 60(11):1909-20. PubMed ID: 25648034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study.
    Durakoğlugil ME; Kocaman SA; Çetin M; Kirbaş A; Canga A; Erdoğan T; Çiçek Y
    Anadolu Kardiyol Derg; 2013 Feb; 13(1):39-44. PubMed ID: 23070634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of endothelial dysfunction and inflammation on slow coronary flow.
    Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between neutrophil gelatinase-associated lipocalin levels and the slow coronary flow phenomenon.
    Aksan G; Soylu K; Aksoy O; Özdemir M; Yanik A; Yuksel S; Gedikli Ö; Gulel O; Sahin M
    Coron Artery Dis; 2014 Sep; 25(6):505-9. PubMed ID: 24801557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute phase reactants in patients with coronary slow flow phenomenon.
    Madak N; Nazlı Y; Mergen H; Aysel S; Kandaz M; Yanık E; Cekdemir D; Tavlı T
    Anadolu Kardiyol Derg; 2010 Oct; 10(5):416-20. PubMed ID: 20929698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon.
    Wang Y; Liu MJ; Yang HM; Ma CY; Jia PY; Jia DL; Hou AJ
    BMC Cardiovasc Disord; 2018 Jul; 18(1):138. PubMed ID: 29973151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum sST2 and sCD40L values in patients with microvascular angina.
    Aslan G; Polat V; Bozcali E; Opan S; Çetin N; Ural D
    Microvasc Res; 2019 Mar; 122():85-93. PubMed ID: 30502363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low bilirubin levels are associated with coronary slow flow phenomenon.
    Oz F; Cizgici AY; Kaya MG; Kurt M; Basibuyuk M; Tufan F; Oflaz H
    Kardiol Pol; 2015; 73(1):40-5. PubMed ID: 25765055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.
    Evrengul H; Tanriverdi H; Enli Y; Kuru O; Seleci D; Bastemir M; Kilic A; Kaftan A; Kilic M
    Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.
    Turhan H; Saydam GS; Erbay AR; Ayaz S; Yasar AS; Aksoy Y; Basar N; Yetkin E
    Int J Cardiol; 2006 Apr; 108(2):224-30. PubMed ID: 16002164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Tascanov MB; Tanriverdi Z; Gungoren F; Besli F; Erkus ME; Gonel A; Koyuncu I; Demirbag R
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31311177
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical analysis of the risk factors of slow coronary flow.
    Xia S; Deng SB; Wang Y; Xiao J; Du JL; Zhang Y; Wang XC; Li YQ; Zhao R; He L; Xiang YL; She Q
    Heart Vessels; 2011 Sep; 26(5):480-6. PubMed ID: 21207039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased neopterin levels and its association with angiographic variables in patients with slow coronary flow: an observational study.
    Varol E; Gülcan M; Aylak F; Ozaydın M; Sütçü R; Erdoğan D; Doğan A
    Anadolu Kardiyol Derg; 2011 Dec; 11(8):692-7. PubMed ID: 22088857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method.
    Yasar AS; Turhan H; Erbay AR; Karabal O; Bicer A; Sasmaz H; Yetkin E
    J Invasive Cardiol; 2005 Feb; 17(2):73-6. PubMed ID: 15687528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between impaired cutaneous microvascular endothelial function and lectin-like oxidized low-density lipoprotein receptor-1 in patients with coronary slow flow.
    Zhao J; Zhang Y; Huang Z; Wu F; Li N; Liang C
    Microvasc Res; 2020 May; 129():103984. PubMed ID: 31954703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased thrombolysis in myocardial infarction frame count in patients with myocardial infarction and normal coronary arteriogram: a possible link between slow coronary flow and myocardial infarction.
    Yetkin E; Turhan H; Erbay AR; Aksoy Y; Senen K
    Atherosclerosis; 2005 Jul; 181(1):193-9. PubMed ID: 15939072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum resistin levels in patients with coronary slow-flow phenomenon.
    Canga A; Cetin M; Kocaman SA; Durakoğlugil ME; Kırbaş A; Erdoğan T; Temiz A; Yılmaz A; Ciçek Y
    Herz; 2013 Nov; 38(7):773-8. PubMed ID: 23400345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Salusin-β Levels Are Correlated with Slow Coronary Flow.
    Wang T; Dong AH; Cao HY
    Genet Test Mol Biomarkers; 2016 Jul; 20(7):393-7. PubMed ID: 27227272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow.
    Barutcu I; Sezgin AT; Sezgin N; Gullu H; Esen AM; Topal E; Ozdemir R; Kosar F; Cehreli S
    Angiology; 2007; 58(4):401-7. PubMed ID: 17652225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
    Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
    Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.